An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer

Molecular Therapy: Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles